ADMA Price To Free Cash Flows Ratio from 2010 to 2024

ADMA Stock  USD 17.45  0.04  0.23%   
ADMA Biologics' Price To Free Cash Flows Ratio is increasing over the years with slightly volatile fluctuation. Overall, Price To Free Cash Flows Ratio is expected to go to 278.34 this year. From 2010 to 2024 ADMA Biologics Price To Free Cash Flows Ratio quarterly data regression line had arithmetic mean of  32.70 and significance of  0.02. View All Fundamentals
 
Price To Free Cash Flows Ratio  
First Reported
2010-12-31
Previous Quarter
265.08967368
Current Value
278.34
Quarterly Volatility
97.10754499
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ADMA Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ADMA Biologics' main balance sheet or income statement drivers, such as Interest Expense of 26.3 M, Other Operating Expenses of 248.4 M or Operating Income of 22.7 M, as well as many indicators such as Price To Sales Ratio of 3.72, Dividend Yield of 0.0694 or PTB Ratio of 7.86. ADMA financial statements analysis is a perfect complement when working with ADMA Biologics Valuation or Volatility modules.
  
Check out the analysis of ADMA Biologics Correlation against competitors.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.

Latest ADMA Biologics' Price To Free Cash Flows Ratio Growth Pattern

Below is the plot of the Price To Free Cash Flows Ratio of ADMA Biologics over the last few years. It is ADMA Biologics' Price To Free Cash Flows Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ADMA Biologics' overall financial position and show how it may be relating to other accounts over time.
Price To Free Cash Flows Ratio10 Years Trend
Slightly volatile
   Price To Free Cash Flows Ratio   
-1.67-2.72-1.46-1.56-10.46265.09278.34100%
       Timeline  

ADMA Price To Free Cash Flows Ratio Regression Statistics

Arithmetic Mean32.70
Coefficient Of Variation296.98
Mean Deviation63.74
Median(2.72)
Standard Deviation97.11
Sample Variance9,430
Range289
R-Value0.59
Mean Square Error6,601
R-Squared0.35
Significance0.02
Slope12.85
Total Sum of Squares132,018

ADMA Price To Free Cash Flows Ratio History

2024 278.34
2023 265.09
2022 -10.46
2021 -1.56
2020 -1.46
2019 -2.72
2018 -1.67

About ADMA Biologics Financial Statements

ADMA Biologics stakeholders use historical fundamental indicators, such as ADMA Biologics' Price To Free Cash Flows Ratio, to determine how well the company is positioned to perform in the future. Although ADMA Biologics investors may analyze each financial statement separately, they are all interrelated. For example, changes in ADMA Biologics' assets and liabilities are reflected in the revenues and expenses on ADMA Biologics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ADMA Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Free Cash Flows Ratio 265.09  278.34 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out the analysis of ADMA Biologics Correlation against competitors.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.27
Revenue Per Share
1.661
Quarterly Revenue Growth
0.781
Return On Assets
0.1989
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.